|
|
|
|
Lexicon Files Application With FDA For Type-2 Diabetes Treatment LX4211
(financialwire.net via COMTEX) -- LXRX | Quote | Chart | News | PowerRating -- December 2, 2008 (FinancialWire) -- Lexicon Pharmaceuticals Inc.(NASDAQ: LXRX | Quote | Chart | News | PowerRating) has submitted an investigational new drug...
|
|
|
Genes and Diabetes Increase Heart Problems
(Ivanhoe Newswire) -- Type 2 diabetes is a known risk factor for cardiovascular disease.It increases a persons risk of having a major cardiac event in their lifetime by two to four times compared to people without diabetes. Now...
|
|
|
Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
* New Oral Small Molecule Drug Candidate for Type 2 Diabetes * SGLT2 Inhibition Shown to Reduce Blood Glucose Levels and Body Weight * Phase 1 Clinical Trials to Begin Following FDA Review THE WOODLANDS, Texas, Dec.1, 2008 ...
|
|
|
Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
* New Oral Small Molecule Drug Candidate for Type 2 Diabetes * SGLT2 Inhibition Shown to Reduce Blood Glucose Levels and Body Weight * Phase 1 Clinical Trials to Begin Following FDA Review THE WOODLANDS, Texas, Dec.1, 2008 ...
|
|
|
Diamyd Medical: Diamyd Diabetes Vaccine - Three Blockbuster Indications
Diamyd Medical reports that the Diamyd vaccine may be effective in preventing type 1 diabetes in individuals that have not yet presented clinical symptoms.STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: As reported in New...
|
|
|
Diamyd Medical: Diamyd Diabetes Vaccine - Three Blockbuster Indications
Diamyd Medical reports that the Diamyd vaccine may be effective in preventing type 1 diabetes in individuals that have not yet presented clinical symptoms.STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: As reported in New...
|
|
|
Genes and Diabetes Increase Heart Problems
(Ivanhoe Newswire) -- Type 2 diabetes is a known risk factor for cardiovascular disease.It increases a person's risk of having a major cardiac event in their lifetime by two to four times compared to people without diabetes. Now...
|
|
|
Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
* New Oral Small Molecule Drug Candidate for Type 2 Diabetes * SGLT2 Inhibition Shown to Reduce Blood Glucose Levels and Body Weight * Phase 1 Clinical Trials to Begin Following FDA Review THE WOODLANDS, Texas, Dec.1, 2008 ...
|
|
|
Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
* New Oral Small Molecule Drug Candidate for Type 2 Diabetes * SGLT2 Inhibition Shown to Reduce Blood Glucose Levels and Body Weight * Phase 1 Clinical Trials to Begin Following FDA Review THE WOODLANDS, Texas, Dec.1, 2008 ...
|
|
|
Report Shows Approximately 420,000 Wisconsin Adults Have Diabetes
State health officials are stressing a healthier lifestyle as a new Department report shows that one in every 10 Wisconsin adults has diabetes, making the disease a major health concern.'It's fair to describe the spread of diabetes in...
|
|
|
Cancer Drugs Reverse Type 1 Diabetes in Mice
According to a new animal study, a class of cancer-fighting drugs may have some Type-1-diabetesfighting potential.The study found that treating mice that had recently developed Type 1 diabetes with the drugs imatinib (brand...
|
|
|
GENFIT: Therapeutic Potential Of Gft505 Is Demonstrated In The Treatment Of Cardiovascular Risk Associated Wit
Also Included In: Diabetes email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a...
|
|
|
Diabetes Type 2 causes, prevention and control
CST The New England Journal of Medicine this week has one of those hard to read but exceedingly important reports on a significant bit of medical investigation.Diabetes Type 2 is definitely a disease that some families have...
|
|
|
Trial Results Don't Look Good for GlaxoSmithKline's Diabetes Drug
Avandia (rosiglitazone) has been under suspicion for the last couple of years, after data appeared suggesting a higher rate of cardiovascular problems with its use.GlaxoSmithKline (GSK) has been disputing this association all the way, as...
|
|
|
Two Cancer Drugs Show Promise For Preventing and Reversing Type 1 Diabetes
Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes.'The findings suggest that kinase inhibitors successfully used in cancer may...
|
|
|
Hope for Type 1 Diabetes Patients
In type 1 diabetes, insulin-producing beta cells are destroyed by the immune system, leading the pancreas to produce little or no insulin.The discovery could lead to a new type of replacement therapy for type 1 diabetes...
|
|
|
Diabetes, Gene Variation Linked With Risk of Coronary Artery Disease
Newswise Patients with type 2 diabetes who have poor glycemic control and a certain genetic variation have an increased risk of coronary artery disease, according to a study in the November 26 issue of JAMA.Among the known risk...
|
|
|
Diabetes, Gene Variation Linked With Risk of Coronary Artery Disease
Newswise - Patients with type 2 diabetes who have poor glycemic control and a certain genetic variation have an increased risk of coronary artery disease, according to a study in the November 26 issue of JAMA.Among the known risk...
|
|
|
Fear of hypoglycemia a barrier to exercise for type 1 diabetics
According to a new study, published in the November issue of Diabetes Care, a majority of diabetics avoid physical activity because they worry about exercise-induced hypoglycemia (low blood sugar) and severe consequences including loss...
|
|
|
Gene Variation For Diabetics Associated With Increased Risk of Coronary Artery Disease
Patients with type 2 diabetes who have poor glycemic control and a certain genetic variation have an increased risk of coronary artery disease, according to a new study.Among the known risk factors for cardiovascular disease,...
|
|
|
Genetic Testing No Help in Predicting Type 2 Diabetes
Traditional risk factors, such as obesity, are just as useful, studies find Testing for 18 different gene variations associated with type 2 diabetes was no better at predicting a person's risk for the blood sugar disease than a doctor...
|
|
|
Genetic variation for persons with diabetes linked to greater risk of coronary artery disease
Medical Research News Patients with type 2 diabetes who have poor glycemic control and a certain genetic variation have an increased risk of coronary artery disease, according to a study in the November 26 issue of.Among the known...
|
|
|
Depression alongside diabetes a 'double-whammy' for patients
Diabetes and depression often go hand in hand.Mary Baker was diagnosed with type 2 diabetes in 1998 and, while managing her condition and its complications, she has also had to cope with periods of depression for much of the...
|
|
|
Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes
Alessandro Doria, MD, PhD, MPH; Joanna Wojcik, MD; Rui Xu, MD, PhD; Ernest V.Gervino, ScD; Thomas H. Hauser, MD, MMSc, MPH; Michael T. Johnstone, MD; David Nolan, BS; Frank B. Hu, MD, PhD; James H. Warram, MD, ScD Context A common...
Journal of the American Medical Association:
Nov 25 2008 10:28PM
Matching: type diabetes
|
Find similar documents
|
|
|
|
New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk
Hispanic and African Americans Most in Need of Help to Meet Diabetes Goal WASHINGTON, November 24, 2008 /PRNewswire/ -- According to a new survey released today, the vast majority of Americans at risk for type 2 diabetes -- a...
|
